Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 8613920 Treatment of amyloidogenic diseases

Overview Structured Data Issues Contributors Activity

Is a

Date Filed

July 27, 2007

Date of Patent

December 24, 2013

Patent Application Number

12297636

Patent Citations Received

US Patent 12071472 Methods of reducing toxicity induced by Amyloid beta (A-beta) oligomers using antibodies specific to A-beta oligomers

0

US Patent 11801316 Cromolyn derivatives and related methods of imaging and treatment

US Patent 11905318 Cyclic compound/peptide comprising an A-beta13-16 peptide and a linker that is covalently coupled to the n-terminus residue and the c-terminus residue of the A-beta13-16 peptide

0

US Patent 11970522 Cyclic compound/peptide comprising an A-beta15-18 peptide and a linker that is covalently coupled to the n-terminus residue and the c-terminus residue of the A-BETA15-18 peptide

0

US Patent 11666669 Cromolyn derivatives and related methods of imaging and treatment

0

US Patent 11679095 Macrophages/microglia in neuro-inflammation associated with neurodegenerative diseases

0

US Patent 11779629 Compositions comprising cyclic peptides derived from an A-beta peptide

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

Patent Primary Examiner

Kimberly A Ballard

Find more entities like US Patent 8613920 Treatment of amyloidogenic diseases

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool

By using this site, you agree to our Terms of Service.